EGF and cancer: Furthermore, it interacts with Wnt/β-catenin signalling and with epidermal growth factor (EGF) signalling to enhance epithelial-mesenchymal transition (EMT) and maintenance of cancer stem cells (CSC) [[70], [71], [72], [73]].